Molecular Characterization of Multiple Myeloma Ethnic Disparity

Archived

Food and Drug Administration

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.

Who can apply

  • Others

Contact

Vieda Hubbard <br/>Grants Management Specialist <br/>Phone 240-402-7588
vieda.hubbard@fda.hhs.gov

Key dates & funding
  • PostedMay 22, 2015
  • ClosesJul 21, 2015
  • Award floor$172,000
  • Award ceiling$172,000
  • Program funding$278,000
  • Expected awards1
  • CFDA93.103
Categories
Health IS

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro